NCT06470607 The Lymphocytic Infiltrate of Lung Tumors.
| NCT ID | NCT06470607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Scientific Institute San Raffaele |
| Condition | Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2023-01-20 |
| Primary Completion | 2026-01-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2023-01-20 with a primary completion date of 2026-01-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.
Eligibility Criteria
Inclusion Criteria: * Ability to provide informed consent; * Men and women over the age of 18; * Patients candidates for surgical treatment diagnosed with thoracic tumors Exclusion Criteria: * Previous chemotherapy for any cancer within the last 6 months; * Pregnant and/or breastfeeding women; * Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive/immunomodulatory treatments)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06470607 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06470607 currently recruiting?
Yes, NCT06470607 is actively recruiting participants. Contact the research team at novellis.pierluigi@hsr.it for enrollment information.
Where is the NCT06470607 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06470607 clinical trial?
NCT06470607 is sponsored by Scientific Institute San Raffaele. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.